Consistently, survival data for specific cancer types, including breast invasive carcinoma, liver hepatocellular carcinoma, lung adenocarcinoma, and kidney cancer, also indicate that a higher SLC7A11 expression level predicts a worse prognosis (UALCAN, https://ualcan.path.uab.edu). Here, SLC7A11 is linked to lung adenocarcinoma.